Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
MDM | no reaction to a brilliant announcement | 15:25 | 2 | 365 | |||
|
|||||||
MDM | true to form | 15:24 | 5 | 1.7K | |||
|
|||||||
MDM | go go go | 10/10/22 | 1 | 787 | |||
|
|||||||
MDM | watching? | 08/04/21 | 5 | 1.9K | |||
|
|||||||
MDM | svc is the new mdm | 08/04/21 | 1 | 760 | |||
|
|||||||
MDM | a heart beat | 02/07/07 | 0 | 363 | |||
|
|||||||
MDM | up 2 days running | 26/04/07 | 0 | 196 | |||
|
|||||||
MDM | breaking up | 20/07/06 | 0 | 541 | |||
|
See All Discussions